Executive dysfunction based on an impaired frontal lobe-subcortical loop in the early stage of the disease is regulated by the catechol-O-methyltransferase genotype and dopaminergic drugs, is not related to overall cognitive decline and dementia in the next five years, and often has a good prognosis [26]. This evidence concerns the gene COMT and Mental deterioration.